Matthew Heil Email

Chief Scientific Officer . Curemark

Current Roles

Employees:
28
Revenue:
$4.3M
About
Curemark, LLC is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Curemark's pipeline includes preclinical and clinical-stage programs for the treatment of Autism, ADHD, addiction, Schizophrenia and Parkinson's disease.
Curemark Address
411 Theodore Fremd Ave.
Rye, NY
United States
Curemark Email